Key takeaways:
- Very early pregnancy testing was common among planners, with 40.7% testing more than 4 days before their expected period, and was linked to substantially higher rates of negative results before a positive.
- A history of miscarriage—especially as the most recent pregnancy outcome—was associated with earlier and more frequent testing behavior.
- Investigators stopped short of recommending formal guidance on test timing, noting that future work on maternal anxiety and mental health outcomes will be needed before clinical recommendations can be made.
Findings from PRESTO (Pregnancy Study Online), a large North American preconception cohort study, shed light on factors driving the timing and frequency of pregnancy testing.1
The analysis examined 20,458 pregnancy tests across 6569 unique participants enrolled between 2018 and 2024. Participants reported day-specific testing behavior spanning 4 days before through 4 days after their expected period, allowing investigators to characterize both the timing and frequency of testing and link those patterns to pregnancy detection outcomes.
Of the participants, 40.7% engaged in very early testing, defined as testing more than four days before their expected period. Testing intensity varied widely, with some participants testing only once and others testing daily.
Among participants who detected a pregnancy, very early testers were more than 5 times more likely to receive a negative test result before a positive one compared to those who waited until the day of their expected period (aRR 5.89; 95% CI, 4.73–7.33). Very early testers were also more than three times more likely to experience an initial positive result followed by a negative result, likely reflecting increased detection of very early pregnancy losses (aRR 3.80; 95% CI, 2.12–6.80).
"I believe that knowledge is power, and I hope that being able to weigh the benefits and drawbacks of different testing approaches empowers women to make informed decisions about testing that align with their values," said Alexandra Sundermann, MD, PhD, a study investigator.